Drug monitoring assay

Details for Australian Patent Application No. 2008303540 (hide)

Owner Novartis AG

Inventors Schaefer, Judith; Legay, Francois; Albientz, Patrick; Marbach, Peter; Marrony, Severine; Hillenbrand, Rainer; Grenet, Jean-Miche

Agent Davies Collison Cave

Pub. Number AU-B-2008303540

PCT Pub. Number WO2009/040409

Priority 07117444.5 27.09.07 EP

Filing date 26 September 2008

Wipo publication date 2 April 2009

Acceptance publication date 26 April 2012

International Classifications

G01N 33/94 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving narcotics

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/040409 Priority application(s): WO2009/040409

26 April 2012 Application Accepted

  Published as AU-B-2008303540

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008303541-Oxadiazoleand oxazole-substituted benzimidazoleand indole-derivatives as DGAT1 inhibitors

2008303538-Electrochemical device for biocide treatment in agricultural applications